The information below is intended only to provide the recommendations and rationale from the Committee to Evaluate Drugs (CED) and the Executive Officer decisions regarding the listing of products on the Formulary, funding of cancer drugs through the New Drug Funding Program, funding through the Exceptional Access Program, or funding through the Special Drugs Program.

For further details on what types of information is provided, please refer to the Transparency of the Drug Review Process.

Do not rely upon any of the information provided on this site for medical diagnosis or treatment. Please consult your primary health care provider about any personal health concerns. This website does not provide any medical diagnosis, symptom assessment, health counseling or medical opinion for individual users. The information contained on this site is intended for information purposes only and does not constitute medical advice for patients. For more detailed information on prescription drugs, please consult a qualified healthcare professional.

List alphabetically archives

BRAND NAME	GENERIC NAME	DATE PUBLISHED
OCTOBER 2011
Avastin – GBM	bevacizumab	October 2011
Fludara – CLL	fludarabine tablet	October 2011
Metvix	methyl aminolevulinate	October 2011
Rituxan – CLL	rituximab	October 2011
MAY 2011
Adcirca	tadalafil	May 2011
Afinitor	everolimus	May 2011
Orencia	abatacept	May 2011
Torisel	temsirolimus	May 2011
Vidaza	azacitidine	May 2011
APRIL 2011
Erbitux – head & neck cancer	cetuximab	April 2011
Erbitux – metastatic colorectal cancer	cetuximab	April 2011
Prolastin	alpha1-proteinase inhibitor	April 2011
Simponi – ankylosing spondylitis	golimumab	April 2011
Simponi – psoriatic arthritis	golimumab	April 2011
Simponi – rheumatoid arthritis	golimumab	April 2011
FEBRUARY 2011
Tysabri	natalizumab	February 2011
JANUARY 2011
Gleevec – ALL	imatinib	January 2011
Long-Acting medications for Attention Deficit Hyperactivity Disorder (ADHD)	long-acting medications for attention deficit hyperactivity disorder (ADHD)	January 2011
Sprycel – ALL	dasatinib	January 2011
Thelin	sitaxsentan	January 2011
DECEMBER 2010
Januvia	sitagliptin	December 2010
NOVEMBER 2010
Leukotriene Receptor Antagonists (Singulair, Accolate)	leukotriene receptor antagonists (montelukast, zafirlukast)	November 2010
AUGUST 2010
Levemir Penfill	insulin detemir	August 2010
Lantus SoloStar	insulin glargine	August 2010
Humalog Mix50	insulin lispro/insulin lispro protamine	August 2010
Cymbalta for DPN	duloxetine for DPN	August 2010
Azilect	rasagiline	August 2010
JULY 2010
Actonel 75mg and 150mg	risedronate sodium	July 2010
Combination treatment for Pulmonary Arterial Hypertension (PAH)		July 2010
Fosavance 70/140	alendronate-cholecalciferol	July 2010
Revatio	sildenafil	July 2010
Volibris	ambrisentan	July 2010
JUNE 2010
Seroquel XR	quetiapine fumarate	June 2010
Mezavant	mesalamine (5-ASA)	June 2010
Ralivia	tramadol hydrochloride ER	June 2010
Tridural	tramadol hydrochloride ER	June 2010
Zytram XL	tramadol hydrochloride XL	June 2010
Xarelto	rivaroxaban	June 2010
APRIL 2010
Advagraf	tacrolimus (extended-release)	April 2010
Abraxane	nab-paclitaxel	April 2010
Resultz	isopropyl myristate	April 2010
Faslodex	fulvestrant	April 2010
MARCH 2010
Exjade	deferasirox	March 2010
Kaletra pediatric tablet	lopinavir / ritonavir	March 2010
FEBRUARY 2010
Aldara	imiquimod	February 2010
Atacand	candesarten cilexetil	February 2010
Biphentin	methylphenidate extended release	February 2010
Fluanxol Depot	flupenthixol decanoate	February 2010
Nuvaring	etonogestrel / ethinyl estradiol	February 2010
Rebif initiation package	interferon beta1a	February 2010
Vantas	histrelin acetate	February 2010
DECEMBER 2009
Myozyme	alglucosidase alfa	December 2009
NOVEMBER 2009
Cubicin	daptomycin	November 2009
Eprex - additional dosage forms	epoetin alfa - additional dosage forms	November 2009
Invega	paliperidone	November 2009
Omnaris	ciclesonide	November 2009
One-Alpha	alfacalcidol	November 2009
OCTOBER 2009
Adderall XR	mixed amphetamine salts	October 2009
Celsentri	maraviroc	October 2009
Cosopt Preservative Free	dorzolamide/timolol	October 2009
Diovan-HCT	valsartan/ hydrochlorothiazide	October 2009
Exelon Patch	rivastigmine patch	October 2009
Rasilez	aliskiren	October 2009
Stalevo	levodopa/ carbidopa/ entacapone	October 2009
Xeloda	capecitabine (as component of CAPOX regimen)	October 2009
SEPTEMBER 2009
Avastin - for metastatic colorectal cancer	bevacizumab	September 2009
Elaprase	idursulfase	September 2009
APRIL 2009
Posanol	posaconazole	April 2009
Revlimid – myelodysplastic syndrome	lenalidomide	April 2009
Seasonale	levonorgestrel / ethinyl estradiol	April 2009
MARCH 2009
Intelence	etravirine	March 2009
Lantus	insulin glargine	March 2009
FEBRUARY 2009
Hyzaar	losartan/hydrochlorothiazide	February 2009
Vectibix	panitumumab	February 2009
JANUARY 2008
Aclasta – osteoporosis	zoledronic acid	January 2009
Nexavar – hepatocellular carcinoma	sorafenib	January 2009
Rituxan – rheumatoid arthritis	rituximab	January 2009
DECEMBER 2008
Levaquin 750mg	levofloxacin	December 2008
Sensipar	cinacalcet	December 2008
Sprycel – chronic myeloid leukemia	dasatinib	December 2008
NOVEMBER 2008
Cipralex	escitalopram	November 2008
Combigan 10mL – new package size	brimonidine/timolol	November 2008
OCTOBER 2008
Dovobet	calcipotriol/betamethasone	October 2008
Eloxatin – adjuvant treatment of colorectal cancer	oxaliplatin	October 2008
Eloxatin – metastatic colorectal cancer	oxaliplatin	October 2008
Nexavar – metastatic renal cell carcinoma	sorafenib	October 2008
AUGUST 2008
Alimta – non-small cell lung cancer	pemetrexed	August 2008
Aromasin – early breast cancer	exemestane	August 2008
Gemzar – metastatic breast cancer	gemcitabine hydrochloride	August 2008
Hycamtin – small cell lung cancer	topotecan	August 2008
Kaletra	lopinavir/ritonavir	August 2008
MabCampath	alemtuzumab	August 2008
Trosec	trospium chloride	August 2008
Xeloda – gastric cancer	capecitabine	August 2008
JUNE 2008
Altace HCT	ramipril/hydrochlorothiazide	June 2008
Aricept RDT	donepezil rapidly dissolving tablet	June 2008
Denavir	penciclovir	June 2008
Exjade	deferasirox	June 2008
Lucentis	ranibizumab	June 2008
Truvada	emtricitabine/tenofovir disoproxil fumarate	June 2008
MAY 2008
Alvesco	ciclesonide	May 2008
DDAVP Melt	desmopressin	May 2008
Elaprase	idursulfase	May 2008
Hypurin	insulin porcine	May 2008
Revatio	sildenafil	May 2008
Sutent – MRCC	sunitinib	May 2008
JANUARY 2008
Prezista	darunavir	January 2008
Linessa	desogestrel/ethinyl estradiol	January 2008
Yasmin	drospirenone/ethinyl estradiol	January 2008
Femara	letrozole	January 2008
Altace 15mg capsule	ramipril 15mg capsule	January 2008
OCTOBER 2007
Duragesic 12	fentanyl 12.5mcg/hr transdermal patch	October 2007
Altace Plus Felodipine	ramipril/felodipine	October 2007
Avalide	irbesartan/hydrochlorothiazide	October 2007
Caelyx – recurrent ovarian cancer	pegylated liposomal doxorubicin	October 2007
Humira – psoriatic arthritis	adalimumab	October 2007
Hycamtin – recurrent ovarian cancer	topotecan	October 2007
Sutent – GIST	sunitinib	October 2007
Taxol – recurrent ovarian cancer	paclitaxel	October 2007
Vfend	voriconazole	October 2007
JULY 2007
Actonel Plus Calcium	risedronate sodium/calcium carbonate	July 2007
Alimta - MPM	pemetrexed	July 2007
Diovan	valsartan	July 2007
Enablex	darifenacin	July 2007
Fosavance	alendronate/cholecalciferol	July 2007
Gleevec - CML	imatinib mesylate	July 2007
Gleevec - GIST	imatinib mesylate	July 2007
OxyContin	oxycodone hydrochloride	July 2007
To view PDF format files, you need to have Adobe Acrobat® Reader installed on your computer.    You can download this free software from the Adobe website.